4-methylpyrazole    (DrugBank: 4-methylpyrazole)

1 disease
告示番号疾患名(ページ内リンク)臨床試験数
301黄斑ジストロフィー1

301. 黄斑ジストロフィー [臨床試験数:41,薬物数:47(DrugBank:12),標的遺伝子数:12,標的パスウェイ数:66
Searched query = "Macular dystrophy", "Best disease", "Stargardt disease", "Cone dystrophy", "Cone rod dystrophy", "X-linked juvenile retinoschisis", "Central areolar choroidal dystrophy"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 41 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00346853
(ClinicalTrials.gov)
November 200528/6/2006Phase 1 Pilot Study of 4-MP to Treat Stargardt Macular DystrophyClinical Interventions Against Stargardt Macular Dystrophy: Phase 1 Pilot Study of 4-MP as an Inhibitor of Dark AdaptationMacular Dystrophy, CornealDrug: 4-Methylpyrazole;Other: salineUniversity of UtahNULLCompleted18 Years65 YearsAll10Phase 1United States